Pharmaceutical Reimbursement a National Health Policy Issue? it May Be the Only Solution to Continuing Payment Problems

Summary:

Solutions to the pharmaceutical payment issues raised in the first part of this two-part article cannot be left unresolved. Numerous options are presented in this article, some of which show little promise for inducing significant change, but others may be the types of approaches that eventually will prove effective in bringing about uniform, adequate payment for state-of-the-art cancer treatment.